Thomas J. Lyons, III

Associate

Thomas Lyons enjoys learning from and about his sophisticated, financial sector clients’ businesses – what they do, their business philosophies, and how their finances work – so he can help advise them in their business ventures.

OVERVIEW

EXPERIENCE

EXPERIENCE

INSIGHTS & EVENTS

OVERVIEW

Thomas Lyons enjoys learning from and about his sophisticated, financial sector clients’ businesses – what they do, their business philosophies, and how their finances work – so he can help advise them in their business ventures.

Thomas concentrates his practice in U.S. securities law and financial regulation, specifically working with clients on matters involving securities, derivatives, financial institutions, investment management, private investment funds, and mergers and acquisitions.

Having observed tumultuous times in the finance world during the first decade of the 2000s, Thomas developed a keen interest in finance, capital markets, and securities.

Prior to joining Barnes & Thornburg, Thomas served as an honors program legal extern in the Office of the Chief Counsel in the Division of Corporation Finance at the U.S. Securities and Exchange Commission and as a legal intern for U.S. Sen. Todd Young, both in Washington, D.C.

In those roles, he researched and drafted memoranda involving cryptocurrencies and reviewed and analyzed filings under the Securities Act of 1933 and the Securities Exchange Act of 1934, including Form S-1 registration statements, Form S-4 registration statements, Form 10-K annual reports, Form 10-Q quarterly reports, and Form 8-K current reports for regulatory compliance. He also researched and analyzed various issues regarding the Tax Cuts and Jobs Act, including, but not limited to, the carried interest deduction, opportunity zone fund formation, 1031 transactions, the mortgage interest deduction, the state and local tax deduction, and estate and generation-skipping transfer taxes.

Thomas J. Lyons, III
Associate

Thomas Lyons enjoys learning from and about his sophisticated, financial sector clients’ businesses – what they do, their business philosophies, and how their finances work – so he can help advise them in their business ventures.

Bar Admissions

Court Admissions

Languages

Practices

Represented Hill-Rom Holdings, Inc., a leading medical technology company with more than 10,000 employees worldwide, in its acquisition of Voalte, Inc., a pioneer and leader in real-time, mobile healthcare communications, for a cash consideration of $180 million and up to an additional $15 million in payments related to the achievement of certain commercial milestones

Represented Hill-Rom Holdings, Inc. in its acquisition of Breathe Technologies, Inc., a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency and neuromuscular diseases, for a cash consideration of $130 million

Represented a biopharmaceutical company in its filing of a base shelf prospectus and corresponding shelf registration statement that allowed the company to offer up to $45 million of common shares, share purchase rights, preferred shares, warrants, or units comprised of one or more of such securities during the period that the base shelf prospectus is effective

Represented technology startup Kerauno, a cloud-based provider of communications-workflow software, in its $25 million Series A venture capital investment; the transaction represents one of the largest Series A Venture deals in Indiana history

Represented an IT and telecommunications company in its $13 million term loan from a global investment and advisory financial services firm

Represented a premiere marketing and production company that produces apparel and merchandise for a variety of groups and organizations in its selling of $7 million in assets to a company that provides turnkey professional quality media guides and stadium advertisements for schools across the nation

Represented Aeterna Zentaris Inc., a specialty biopharmaceutical company engaged in commercializing and developing novel pharmaceutical therapies and diagnostic tests in its offering whereby Aeterna Zentari Inc. entered into a securities purchase agreement with institutional investors in the U.S. to purchase approximately $5.0 million of its common shares in a registered direct offering and warrants to purchase common shares in a concurrent private placement

Before sending mail to your intended recipient, you must first understand the
implications of communicating with Barnes & Thornburg LLP and agree to the
following terms.

Barnes & Thornburg LLP appreciates your visit to the firm’s web site. Our site is
provided for informational purposes only and should not be considered legal
advice. Should you choose to contact an attorney at Barnes & Thornburg LLP (via
E-mail or other means of communication), do not disclose information you regard
to be confidential until the attorney verifies that the firm does not represent other
persons or entities involved in the matter and that the firm is willing to consider
accepting representation. Unless otherwise agreed in advance, all unsolicited
inquiries or information received by Barnes & Thornburg LLP will not be regarded
as confidential.